Submission Details
| 510(k) Number | K121050 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | April 06, 2012 |
| Decision Date | February 07, 2013 |
| Days to Decision | 307 days |
| Submission Type | Traditional |
| Review Panel | General Hospital (HO) |
| Summary | Summary PDF |
K121050 is an FDA 510(k) clearance for the 0.9% SODIUM CHLORIDE INJECTION USP BD POSIFLUSH FLUSH SYRINGE, SF FLUSH SYRINGE, a Saline, Vascular Access Flush (Class II — Special Controls, product code NGT), submitted by Becton, Dickinson & CO (Franklin Lakes, US). The FDA issued a Cleared decision on February 7, 2013, 307 days after receiving the submission on April 6, 2012. This device falls under the General Hospital review panel. Regulated under 21 CFR 880.5200.
| 510(k) Number | K121050 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | April 06, 2012 |
| Decision Date | February 07, 2013 |
| Days to Decision | 307 days |
| Submission Type | Traditional |
| Review Panel | General Hospital (HO) |
| Summary | Summary PDF |
| Product Code | NGT — Saline, Vascular Access Flush |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 880.5200 |
| Definition | Enhance The Performance Of Intravascular Catheters, To Maintain Patency Of The Vascular Catheter When It Is Not In Use. |